NCT07011719 2026-03-13
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc.
Phase 3 Recruiting
Arcus Biosciences, Inc.
AstraZeneca
Ankara University
Incheon St.Mary's Hospital
University Hospital, Linkoeping
AstraZeneca
Sun Yat-sen University